Key Documents

View All Documentation

1614669

USP

Sodium Starch Glycolate Type A

Name: Sodium Starch Glycolate Type A
Brand: USP

United States Pharmacopeia (USP) Reference Standard

Select a Size

Change View

About This Item

Linear Formula:

(C₂H₄O₃)_x · (Na)_x

CAS Number:

9063-38-1

MDL number:

MFCD00460869

NACRES:

NA.24

UNSPSC Code:

41116107

Technical Service

Need help? Our team of experienced scientists is here for you.

Let Us Assist

Properties

grade

pharmaceutical primary standard

API family

starch

manufacturer/tradename

USP

application(s)

pharmaceutical (small molecule)

format

neat

Description

General description

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia. For further information and support please go to the website of the issuing Pharmacopoeia.

Application

Sodium Starch Glycolate Type A USP reference standard, intended for use in specified quality tests and assays as specified in the USP compendia. Also, for use with USP monograph such as Sodium Starch Glycolate

Analysis Note

These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind.

Other Notes

Sales restrictions may apply.

Storage Class

11 - Combustible Solids

flash_point_f

Not applicable

flash_point_c

Not applicable

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number

It looks like we've run into a problem, but you can still download Certificates of Analysis from our Documents section.

If you need assistance, please contact Customer Support

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

A comparison of chitosan-silica and sodium starch glycolate as disintegrants for spheronized extruded microcrystalline cellulose pellets.

Alvaro Goyanes et al.

Drug development and industrial pharmacy, 37(7), 825-831 (2011-03-17)

Chitosan-silica coprecipitate (C-S) has recently been proposed as a tablet disintegrant. In this study we compared it with a 1:1 physical mixture of chitosan and silica (C/S) at the same composition as the coprecipitate, and with the widely used commercial

Application of face centred central composite design to optimise compression force and tablet diameter for the formulation of mechanically strong and fast disintegrating orodispersible tablets.

Ritesh M Pabari et al.

International journal of pharmaceutics, 430(1-2), 18-25 (2012-04-03)

A two factor, three level (3(2)) face centred, central composite design (CCD) was applied to investigate the main and interaction effects of tablet diameter and compression force (CF) on hardness, disintegration time (DT) and porosity of mannitol based orodispersible tablets

Evaluation of physico-mechanical properties of drug-excipients agglomerates obtained by crystallization.

M Maghsoodi et al.

Pharmaceutical development and technology, 16(3), 243-249 (2010-02-24)

Spherical crystallization (SC) of carbamazepine (CBZ) was carried out for preparation of the agglomerates using the solvent change method. The potential of the intraagglomerate addition of sodium starch glycolate (SSG) as a disintegrant agent and povidone (PVP) as a hydrophilic

View All Related Papers

Global Trade Item Number

SKU	GTIN
1614669-400MG	04061838746375